Observational studies should always be considered for inclusion in comparative effectiveness reviews. When deciding whether to include observational studies to assess benefits, reviewers should first determine if there are gaps in evidence from randomized controlled trials. When assessing harms, cohort and case-control studies should be routinely included. If gaps in trial evidence are identified, the review questions should be refocused to those gaps and observational studies addressing them should be included. Studies with high risk of confounding by indication bias are generally not suitable.